Please ensure Javascript is enabled for purposes of website accessibility

Donald Smith Appointed as General Counsel at Argenta

Donald Smith Appointed as General Counsel at Argenta

LONDON, 16 January 2023 – Argenta, the only combined global contract research organisation (CRO) and contract development & manufacturing organisation (CDMO) specialised in animal health, announced today the appointment of Donald Smith as General Counsel, effective immediately.

Donald will be responsible for all legal matters at Argenta, including M&A and corporate governance matters. He will join Argenta’s Executive Leadership Team and reports to Will Downie, CEOat Argenta.

Will Downie said: “Donald has an impressive track record of success with 20 years of experience in major international law firms (including as a Partner) and in a senior in-house role. He has broad expertise in company and commercial law matters for domestic and international corporations, and will bring a skilled and steady hand to the role of general counsel. He is a collaborative and pragmatic leader and possesses the expertise that Argenta needs in this phase of growth.”

Prior to joining Argenta, Donald was a Partner in the Corporate team at Dentons. He got introduced to Argenta years ago when he advised the company on the acquisition of Elanco's Dundee Animal Health business from Eli Lilly &Co.

Donald Smith said: “I am delighted to join the company at this important time and to help in executing its strategic plan. I look forward to working closely with the senior management and the Board of Directors to contribute to the company's success.”

About Argenta™ 

Founded in New Zealand, Argenta’s talented and committed employees are dedicated to delivering excellence in animal health and nutrition to customers around the world. With research and/or GMP manufacturing operations in Germany, New Zealand, Spain, the United Kingdom, and the United States, Argenta holds a unique position as the only combined global contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) specialising in animal health.   

Argenta operates from Molecule to Market in partnership with customers of all sizes from all corners of the world, supporting their research and development, clinical research, regulatory, scale-up and manufacturing needs along the animal health and nutrition product development journey.  

The day-to-day ethos that drives Argenta forward is a mission focused on global partnerships, a Molecule to Market approach, and innovation. At the core of the business and the organisation is collaboration – among the global employee base and with their customers.  

For more information, please visit

Media Contact

Annemieke de Keijzer
+1 732-439-3446

Continue Reading